Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide

Published 2008 View Full Article

Authors

Keywords

Journal

Pharmacogenetics and Genomics

Volume 18, Issue 6, Pages 515-523

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2008-05-15

DOI

10.1097/fpc.0b013e3282fc9766

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

Pharmacogenetics and Genomics

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.